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Abstract
Background: Cardiopulmonary exercise testing is a well-established tool for clinical and
prognostic assessment of patients with chronic heart failure (CHF). Recently, a new parameter
of this examination — oxygen uptake efficiency slope (OUES) — has been described and
proposed as a new prognostic factor in patients with CHF. Brain natriuretic peptide (BNP) is
an established prognostic factor in CHF. The purpose of the study was to assess OUES in
patients with CHF in relation to other cardiopulmonary parameters and BNP levels.
Methods: The study group consisted of 42 patients with CHF and left ventricular ejection
fraction (LVEF) < 45% (mean age 50.2 ± 9.3 years, mean ejection fraction 26.1 ± 8.1% and
NYHA functional class — 2.5 ± 0.8) and eight healthy controls (age 43.6 ± 14.7 years).
Coronary artery disease was diagnosed in 16 patients (38%). All underwent maximal cardio-
pulmonary exercise treadmill test. BNP level was measured using Abbott AxSYM Immuno-
assay system.
Results: There were significant (p < 0.001) differences between the patients and controls in
BNP levels (350 ± 520 vs 14 ± 19 pg/mL), OUES (1.7 ± 0.4 vs 2.7 ± 0.5), peak VO2 (17.1 ±
± 5.1 vs 36.9 ± 4.9 mL/kg/min), O2 pulse (10.9 ± 3.3 vs 15.9 ± 2.7) and VE/VCO2 slope
(35.7 ± 7.8 vs 25.7 ± 2.7). In patients, OUES was significantly (p < 0.001) correlated with
LVEF (r = 0.54), BNP levels (r = –0.49), peak VO2 (r = 0.80), VO2 AT (r = 0.65) and
VE/VCO2 slope (r = –0.59). BNP was independently related to OUES in multivariate regres-
sion analysis.
Conclusions: Oxygen uptake efficiency slope is significantly reduced in patients with CHF
and correlates with peak VO2 and other parameters of cardiopulmonary exercise treadmill test.
It is not related to age. BNP is an independent marker of OUES in patients with CHF.
(Cardiol J 2010; 17, 4: 362–366)
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Introduction
Cardiopulmonary exercise testing (CPX) is a well-
-established tool for clinical and prognostic assess-
ment of patients with chronic heart failure (CHF),
and peak VO2 is its most commonly used parame-
ter in the assessment of functional status and prog-
nosis [1, 2].
The main concern about the assessment of
peak oxygen consumption (VO2) is the achievement
of really maximal effort during exercise test. Many
patients are unable to perform maximal exercise as
evaluated by reaching the respiratory exchange
ratio (RER) just above 1 or even more. During the
last decade, many investigators have shown that
a ventilatory response to exercise expressed as
a minute ventilation (VE)/carbon dioxide production
(VCO2) slope can predict prognosis even better than
peak VO2 [3–5]. It can be used as a prognostic fac-
tor also in patients who performed only submaximal
effort [5]. Recently, another measure of ventilatory
response to exercise, referred to as oxygen uptake
efficiency slope (OUES), has been described and
proposed as a new prognostic indicator in CHF pa-
tients [6]. OUES represents the relationship be-
tween O2 and ventilation during incremental exer-
cise and is the absolute increase in VO2 associated
with a 10-fold rise in ventilation. OUES is described
as the regression slope ‘a’ in equation VO2 = a log
VE + b. It was shown to correlate with peak VO2
and VE/VCO2 slope [6, 7].
Brain natriuretic peptide (BNP) secreted by
cardiomyocytes in response to ventricular wall
stretch is a well-known marker of neurohormonal
activation, and is also an important predictor in CHF
[8]. It has been shown that plasma BNP is related
to the enhanced ventilatory response to exercise
expressed as a VE/VCO2 slope [9]. However, the
relationship between abnormal neurohormonal ac-
tivation and OUES is unknown.
In this study, we have assessed OUES in pa-
tients with CHF in relation to other cardiopulmo-
nary parameters and BNP levels.
Study population and design
The study group consisted of 42 consecutive
patients with CHF, and left ventricular ejection frac-
tion (LVEF) below 45%, referred for cardiopulmo-
nary exercise testing. The control group consisted
of eight healthy subjects. At the time of examina-
tion, all patients were in a stable clinical condition
and taking optimal medical therapy. Exclusion cri-
teria included: recent myocardial infarction or re-
vascularization (£ three months), exertional angi-
na or arrhythmias, atrial fibrillation, severe pulmo-
nary disease, severe renal insufficiency or other
organ disorders significantly altering physical capa-
city. Thirty seven patients (88%) were treated with
angiotensin-converting enzyme inhibitor or angio-
tensin receptor blocker, 39 (93%) with beta-block-
ers, 36 (86%) received furosemid, 27 (64%) aldos-
teron antagonist, 10 (24%) digoxin, 24 (57%) aspi-
rin, and 10 (24%) antiarrhythmics.
All underwent maximal cardiopulmonary exer-
cise treadmill test performed according to the modi-
fied Bruce protocol (adding stage 0: 3 min, 1.7 km/h,
5% grading). The peak VO2, carbon dioxide produc-
tion, and minute ventilation were measured with
breath by breath technique, using Sensor Medics,
model Vmax29. The equipment was calibrated be-
fore each test. Patients were encouraged to contin-
ue to the limit of their symptoms by the supervis-
ing physician. There was continuous electrocardio-
graphy (ECG) monitoring and blood pressure was
measured at each stage of exercise. Peak VO2 was
defined as the highest 20 s average during the last
60 s of exercise. The predicted VO2% was calculat-
ed using Wasserman’s equation [10]. RER > 1.0
was taken to represent adequate effort. VE/VCO2
slope was calculated for the whole exercise period.
Ventilatory anaerobic threshold (VAT) was calcu-
lated by the V-slope method. OUES was defined as
the gradient of the linear relationship between
log10VE and VO2 (L/min) [11].
Venous blood was drawn before the exercise
test after at least 20 minutes of rest (supine posi-
tion). BNP levels were measured using the Abbott
AxSYM Immunoassay system.
All subjects gave their informed consent to par-
ticipate and the study protocol was approved by the
Ethics Committee of our University of Medical
Sciences.
Statistical analysis
The values are given as means and standard
deviations. Student t-test, Mann-Whitney and
c2 analyses were used to evaluate the significance
of differences between groups. Correlations be-
tween variables were assessed using the Spearman
rank test. Multivariate regression analysis was used
to assess which of the statistically significant cor-
relations between variables were independently
correlated with OUES. A p value of < 0.05 was tak-
en to be statistically significant. All analyses were
performed using the Statistica 7.0 package.
Results
The mean age of 42 study patients was 50.2 ±
± 9.3 years and eight (19%) were females. The
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mean LVEF (assessed by ECHO) was 26.1 ± 8.1%
and NYHA functional class — 2.5 ± 0.8. Coronary
artery disease (CAD) was diagnosed in 16 patients
(38%) and dilated cardiomyopathy (DCM) in 26
(62%). The mean age of the eight healthy controls
was 43.6 ± 14.7 years, and two of them (25%) were
females. Clinical characteristics of the study popu-
lation are shown in Table 1 and the results of the
exercise test in Table 2. We were able to determine
ventilatory threshold in 35 patients (83%).
OUES did not correlate with age, body mass
index (BMI), or peak heart rate. There was a trend
towards men having higher OUES than women (Fig. 1).
There were significant correlations between OUES
and LVEF (r = 0.54; p = 0.0003), peak VO2 (r = 0.80;
p = 0.0001, Fig. 2), VO2 AT (r = 0.65; p =  0.00003),
O2 pulse (r = 0.79; p =0.0001) and peak systolic
blood pressure (SBP) (r = 0.42; p = 0.005) and inverse
correlations between OUES and VE/VCO2 slope
(r = –0.59; p = 0.00003), and BNP levels (r = –0.49;
p = 0.0009, Fig. 3). In multivariate regression
Table 1. Clinical characteristics of patients with
chronic heart failure (CHF) and controls.
CHF Controls P
(n = 42)  (n = 8)
Age (years) 50.2 ± 9.3 43.6 ± 14.7 NS
Men (%) 34 (81%) 6 (75%) NS
LVEF (%) 26.1 ± 8.1 – –
NYHA class 2.5 ± 0.8 – –
BMI [kg/m²] 28.2 ± 4.5 23.7 ± 2.0 0.008
BNP [pg/mL] 350 ± 520 14 ± 19 0.0005
LVEF — left ventricular ejection fraction; NYHA — New York Heart
Association; BMI — body mass index; BNP — brain natriuretic peptide;
NS — non-significant
Table 2. Cardiopulmonary exercise test results in
patients with chronic heart failure (CHF) and
controls.
CHF Controls P
(n = 42)  (n = 8)
Peak VO2 17.1 ± 5.1 36.9 ± 4.9 < 0.0001
[mL/kg/min]
VO2 AT 11.9 ± 3.0 21.5 ± 2.7 < 0.0001
[mL/kg/min]
AT detected (%) 34 (81%) 8 (100%) NS
O2 pulse 10.9 ± 3.3 15.9 ± 2.7 0.0002
VE/VCO2 slope 35.7 ± 7.8 25.7 ± 2.7 0.0009
OUES 1.7 ± 0.4 2.7 ± 0.5 < 0.0001
VO2 — oxygen consumption; VCO2 — carbon dioxide production;
VE — minute ventilation; AT — anaerobic threshold; OUES — oxy-
gen uptake efficiency slope
Figure 1. Oxygen uptake efficiency slope in males and
females.
Figure 3. Correlation between oxygen uptake efficiency
slope (OUES) and brain natriuretic peptide (BNP) levels
in patients with chronic heart failure.
Figure 2. Correlation between oxygen uptake efficiency
slope (OUES) and peak oxygen consumption (VO2) in
patients with chronic heart failure.
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analysis (R2 = 0.58, p < 0.0001) with inclusion of
LVEF, gender, BNP levels and peak SBP indepen-
dently associated with OUES were the following:
gender (b = 0.27; p = 0.02) LVEF (b = 0.42;
p = 0.002), and BNP (b = –0.27; p = 0.04). There
were significant correlations between VE/VCO2
slope and LVEF (r = –0.58; p = 0.00005), peak VO2,
VO2 AT, O2 pulse, peak SBP, and heart rate, and BNP
levels. No differences were observed in VE/VCO2
slope between men and women. VE/VCO2 slope did
not correlate with age or BMI. In multivariate regres-
sion analysis (R2 = 0.53, p < 0.00001) including
LVEF, BNP levels, peak heart rate and peak SBP,
independently associated with VE/VCO2 slope were:
LVEF (b = –0.43; p = 0.002), and BNP (b = 0.28;
p = 0.055).
Discussion
The available data shows that OUES is signi-
ficantly reduced in patients with CHF and is corre-
lated with peak VO2 and other parameters of CPX.
It is not related to age. BNP is an independent mark-
er of OUES in patients with CHF.
Cardiopulmonary exercise test is an esta-
blished method of evaluation of functional status and
prognosis in patients with CHF [2, 12]. Despite
known limitations (measurement is strongly influ-
enced by the patient’s motivation and the tester’s
subjective choice of test end), peak VO2 remains the
most important parameter of CPX. The ventilatory
threshold, which was proposed for assessment and
to eliminate the influence of subjective motivation,
is unfortunately difficult to obtain in many healthy
subjects, and in up to 25% of patients with CHF [13].
We could not determine VAT in 17% of exam-
ined patients. Peak VO2 is widely used as a prog-
nostic index and traditionally remains the most
important CPX parameter for the selection of those
who may benefit from cardiac transplantation. VE/
/VCO2 was proposed by Corra et al. [14] to improve
the stratification of patients with intermediate peak
VO2 into moderate and high risk groups. Although
VE/VCO2 slope may be derived from the data of
submaximal exercise test, the best prognostic sig-
nificance has the one calculated for the whole ex-
ercise [5, 15, 16]. In the European Society of Car-
diology guidelines for the diagnosis and treatment
of acute and chronic heart failure 2008, VE/VCO2 is
an accepted major prognostic factor, together with
peak VO2 [17]. OUES is a new and promising prog-
nostic marker applicable in cardiac patients unable
to perform true maximal exercise [18]. OUES re-
presents, in principle, the absolute rate of increase
in VO2 per 10-fold increase in ventilation. OUES is
easily obtained through a simple mathematical cal-
culation, and unlike VAT its determination is not af-
fected by subjective interpretation. OUES, when
calculated for the first 75% of the exercise test, dif-
fered only by 1.9% from OUES calculated for 100%
of exercise time in subjects with peak RER ≥ 1.1
[18]. On serial tests OUES was less variable than
exercise duration or peak VO2. Gademan et al. [19]
also did not find significant differences in OUES
calculated for the data derived from the first 75%,
90% and 100% of the entire exercise in patients
with CHF. OUES, first described by Baba et al. [11],
is an index of cardiopulmonary functional reserve
integrating cardiovascular, musculoskeletal and res-
piratory function. The ventilatory response to ex-
ercise and OUES are influenced by CO2 production,
arterial pCO2 and physiological pulmonary dead
space ventilation. Thus, OUES depends on mass of
working muscle, muscle and pulmonary perfusion,
extraction and utilization of oxygen by muscles and
the time of appearance of lactic acidosis. Patients
with CHF who develop lactic acidosis earlier during
exercise, have larger dead space ventilation, and
will be expected to have diminished OUES in com-
parison to healthy subjects, something shown in our
analysis that agrees with other work  [11, 18]. Hol-
lenberg et al. [18] has shown that OUES was influ-
enced by age, body surface area (to normalize total
pulmonary volume) and lean body mass (a surro-
gate of muscle mass). In addition, they found gen-
der differences in OUES, with higher values in men
than women, declining linearly with age, with
a steeper rate of decline in men than in women.
In our study, higher values of OUES were
found in men than women, but there were no cor-
relations with age in patients with CHF. OUES was
strongly correlated with peak VO2 and ventilation,
and less so with VAT, VE/VCO2 slope, something
that tallies with the work of others [6, 7]. Davies et
al. [6] found in a retrospective study that OUES had
a strong prognostic value, even better than that of
standard cardiopulmonary exercise test-derived
variables in patients with CHF. They speculated
that this may be because its calculation specifically
separates the exercise-induced changes in ventila-
tion from any baseline hyperventilation. The best
cut-off value for OUES they obtained was 1.47 L/min.
In our analysis, BNP levels were independent
markers of OUES, together with gender and peak
SBP. Natriuretic peptides are secreted by cardiomy-
ocytes in response to ventricular wall stretch and
are markers of neurohormonal activation in CHF.
Their levels correlate with functional status, peak
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VO2 and prognosis [8, 20]. Van de Veire et al. [21]
found in patients with coronary artery disease (with
preserved and with poor left ventricular systolic
function; asymptomatic and symptomatic) and
intermediate peak VO2 that OUES was indepen-
dently predicted by gender, peak heart rate and
NT-proBNP. NT-proBNP was also a significant pre-
dictor of VE//VCO2 slope. In our study, BNP was
a predictor of VE/VCO2 slope of borderline signifi-
cance. Scardovi et al. [9] who examined patients
with mild to moderate HF and LVEF < 40% found
that BNP was the only independent predictor of the
enhanced ventilatory response to CPX (which is
defined as VE/VCO2 slope ≥ 35 and has additive
prognostic value in patients with intermediate and
preserved exercise capacity).
Probably, OUES in the same way as VE/VCO2
slope, potentially could also be used to identify
a subgroup of patients who might have a worse
prognosis. Further studies are needed to confirm
its prognostic value in CHF in comparison with BNP
and to establish the best cut-off value.
Conclusions
OUES is significantly reduced in patients with
CHF and correlates with peak VO2 and other para-
meters of CPX. It is not related to age. BNP is an
independent marker of OUES in patients with CHF.
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